(+)-dexrazoxane increases expression ISO RGD:733814 6480464 Dexrazoxane results in increased expression of BNIP3 mRNA CTD PMID:26873546 (+)-epicatechin-3-O-gallate multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein], ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein]] CTD PMID:29061316 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of BNIP3 mRNA CTD PMID:17971868 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BNIP3 mRNA] CTD PMID:31150632 (-)-demecolcine decreases expression ISO RGD:1350913 6480464 Demecolcine results in decreased expression of BNIP3 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein], ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein]] CTD PMID:29061316 (S)-nicotine multiple interactions ISO RGD:733814 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o more ... CTD PMID:22937105 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:733814 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:733814 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 17alpha-ethynylestradiol affects expression ISO RGD:733814 6480464 Ethinyl Estradiol affects the expression of BNIP3 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression ISO RGD:733814 6480464 Ethinyl Estradiol results in decreased expression of BNIP3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:733814 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of BNIP3 mRNA CTD PMID:17942748 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one multiple interactions ISO RGD:733814 6480464 1H-(1 more ... CTD PMID:11592958 1H-pyrazole decreases expression ISO RGD:733814 6480464 pyrazole results in decreased expression of BNIP3 mRNA CTD PMID:17945193 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733814 6480464 [decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BNIP3 mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of BNIP3 mRNA CTD PMID:15251184 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733814 6480464 Tetrachlorodibenzodioxin results in decreased expression of BNIP3 mRNA CTD PMID:15251184 , PMID:15667827 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733814 6480464 Tetrachlorodibenzodioxin results in increased expression of BNIP3 mRNA CTD PMID:21041162 2,4-dinitrobenzenesulfonic acid decreases expression ISO RGD:733814 6480464 2, 4-dinitrobenzenesulfonic acid results in decreased expression of BNIP3 mRNA CTD PMID:30116771 2-hydroxypropanoic acid decreases expression ISO RGD:1350913 6480464 Lactic Acid results in decreased expression of BNIP3 mRNA CTD PMID:30851411 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of BNIP3 mRNA CTD PMID:21061450 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:733814 6480464 3 more ... CTD PMID:19467301 4-hydroxynon-2-enal decreases expression ISO RGD:1350913 6480464 4-hydroxy-2-nonenal results in decreased expression of BNIP3 mRNA CTD PMID:12419474 5-aza-2'-deoxycytidine increases expression ISO RGD:1350913 6480464 Decitabine results in increased expression of BNIP3 mRNA, Decitabine results in increased expression of BNIP3 protein CTD PMID:15942716 more ... 5-aza-2'-deoxycytidine decreases methylation ISO RGD:1350913 6480464 Decitabine results in decreased methylation of BNIP3 promoter CTD PMID:15942716 , PMID:17195906 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1350913 6480464 [Decitabine results in decreased methylation of BNIP3 promoter] which results in increased expression of BNIP3 mRNA CTD PMID:17195906 5-aza-2'-deoxycytidine affects expression ISO RGD:1350913 6480464 Decitabine affects the expression of BNIP3 mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733814 6480464 [Decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of BNIP3 mRNA CTD PMID:15251184 5-aza-2'-deoxycytidine decreases expression ISO RGD:733814 6480464 Decitabine results in decreased expression of BNIP3 mRNA CTD PMID:15251184 5-azacytidine increases expression ISO RGD:1350913 6480464 Azacitidine results in increased expression of BNIP3 mRNA CTD PMID:25446377 5-fluorouracil multiple interactions ISO RGD:1350913 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of BNIP3 mRNA] CTD PMID:15016801 5-fluorouracil affects response to substance ISO RGD:1350913 6480464 BNIP3 affects the susceptibility to Fluorouracil CTD PMID:15067352 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of BNIP3 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of BNIP3 mRNA CTD PMID:19483382 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of BNIP3 mRNA CTD PMID:28959563 actinomycin D multiple interactions ISO RGD:733814 6480464 [Dactinomycin co-treated with TNF protein] results in increased expression of BNIP3 mRNA more ... CTD PMID:11592958 more ... all-trans-retinoic acid multiple interactions ISO RGD:733814 6480464 SOX11 protein promotes the reaction [Tretinoin results in increased expression of BNIP3 mRNA] CTD PMID:17055661 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of BNIP3 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BNIP3 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1350913 6480464 pyrazolanthrone inhibits the reaction [Cadmium results in increased expression of BNIP3 protein] CTD PMID:24824807 antimycin A increases expression ISO RGD:733814 6480464 Antimycin A results in increased expression of BNIP3 mRNA CTD PMID:19304788 arsenite(3-) multiple interactions ISO RGD:733814 6480464 arsenite inhibits the reaction [Dietary Fats results in decreased expression of BNIP3 mRNA] CTD PMID:30302732 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BNIP3 mRNA CTD PMID:19730151 arsenous acid increases response to substance ISO RGD:1350913 6480464 BNIP3 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:15592527 arsenous acid multiple interactions ISO RGD:1350913 6480464 [Arsenic Trioxide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of BNIP3 mRNA, Arsenic Trioxide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BNIP3 mRNA] CTD PMID:25446377 arsenous acid increases expression ISO RGD:1350913 6480464 Arsenic Trioxide results in increased expression of BNIP3 mRNA, Arsenic Trioxide results in increased expression of BNIP3 protein CTD PMID:15592527 , PMID:17530438 atrazine decreases expression ISO RGD:1350913 6480464 Atrazine results in decreased expression of BNIP3 mRNA CTD PMID:22378314 bafilomycin A1 multiple interactions ISO RGD:1350913 6480464 BNIP3 mutant form promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein] more ... CTD PMID:25981168 bafilomycin A1 increases expression ISO RGD:1350913 6480464 bafilomycin A1 results in increased expression of BNIP3 mRNA, bafilomycin A1 results in increased expression of BNIP3 protein CTD PMID:25981168 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of BNIP3 mRNA CTD PMID:19483382 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA CTD PMID:17905399 benzo[a]pyrene increases expression ISO RGD:733814 6480464 Benzo(a)pyrene results in increased expression of BNIP3 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:1350913 6480464 Benzo(a)pyrene results in increased expression of BNIP3 mRNA CTD PMID:30453624 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1350913 6480464 7 more ... CTD PMID:20382639 bezafibrate increases expression ISO RGD:733814 6480464 Bezafibrate results in increased expression of BNIP3 mRNA CTD PMID:17118139 bicalutamide increases expression ISO RGD:1350913 6480464 bicalutamide results in increased expression of BNIP3 mRNA CTD PMID:15790403 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1350913 6480464 Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 mRNA] more ... CTD PMID:26082309 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BNIP3 mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:1350913 6480464 bisphenol A results in decreased methylation of BNIP3 promoter CTD PMID:30352284 bisphenol A affects expression ISO RGD:1350913 6480464 bisphenol A affects the expression of BNIP3 mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BNIP3 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1350913 6480464 bisphenol A results in decreased expression of BNIP3 mRNA CTD PMID:29275510 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of BNIP3 gene CTD PMID:28505145 bortezomib increases expression ISO RGD:1350913 6480464 Bortezomib results in increased expression of BNIP3 protein CTD PMID:20110775 buspirone increases expression EXP 6480464 Buspirone results in increased expression of BNIP3 mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:1350913 6480464 [[Gasoline co-treated with 1-Butanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BNIP3 mRNA CTD PMID:29432896 cadmium atom increases expression ISO RGD:733814 6480464 Cadmium results in increased expression of BNIP3 protein CTD PMID:24824807 cadmium atom increases expression ISO RGD:1350913 6480464 Cadmium results in increased expression of BNIP3 mRNA, Cadmium results in increased expression of BNIP3 protein CTD PMID:24824807 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of BNIP3 protein CTD PMID:24824807 cadmium atom multiple interactions ISO RGD:1350913 6480464 pyrazolanthrone inhibits the reaction [Cadmium results in increased expression of BNIP3 protein], U 0126 inhibits the reaction [Cadmium results in increased expression of BNIP3 protein] CTD PMID:24824807 cadmium dichloride increases expression ISO RGD:1350913 6480464 Cadmium Chloride results in increased expression of BNIP3 mRNA CTD PMID:12760830 , PMID:25596134 cadmium dichloride decreases expression ISO RGD:1350913 6480464 Cadmium Chloride results in decreased expression of BNIP3 mRNA CTD PMID:26472689 caffeine multiple interactions ISO RGD:733814 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 capsaicin decreases expression ISO RGD:1350913 6480464 Capsaicin results in decreased expression of BNIP3 mRNA CTD PMID:19502594 carbamazepine affects expression ISO RGD:1350913 6480464 Carbamazepine affects the expression of BNIP3 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:733814 6480464 Nanotubes, Carbon analog results in increased expression of BNIP3 mRNA, Nanotubes, Carbon results in increased expression of BNIP3 mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:733814 6480464 Nanotubes, Carbon analog results in decreased expression of BNIP3 mRNA, Nanotubes, Carbon results in decreased expression of BNIP3 mRNA CTD PMID:25554681 chloroacetaldehyde increases expression ISO RGD:1350913 6480464 chloroacetaldehyde results in increased expression of BNIP3 mRNA CTD PMID:25596134 chloropicrin increases expression ISO RGD:1350913 6480464 chloropicrin results in increased expression of BNIP3 mRNA CTD PMID:26352163 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of BNIP3 mRNA CTD PMID:25596134 ciguatoxin CTX1B affects expression ISO RGD:733814 6480464 Ciguatoxins affects the expression of BNIP3 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:733814 6480464 Cisplatin results in increased expression of BNIP3 mRNA CTD PMID:21074548 cisplatin multiple interactions ISO RGD:1350913 6480464 [2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one co-treated with Cisplatin] results in decreased expression of BNIP3 mRNA more ... CTD PMID:29690507 cisplatin decreases expression ISO RGD:1350913 6480464 Cisplatin results in decreased expression of BNIP3 mRNA CTD PMID:29690507 cisplatin affects expression ISO RGD:1350913 6480464 Cisplatin affects the expression of BNIP3 mRNA CTD PMID:23300844 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BNIP3 mRNA CTD PMID:21575413 cisplatin increases phosphorylation ISO RGD:733814 6480464 Cisplatin results in increased phosphorylation of BNIP3 protein CTD PMID:22006019 clodronic acid decreases expression ISO RGD:1350913 6480464 Clodronic Acid results in decreased expression of BNIP3 mRNA CTD PMID:25596134 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of BNIP3 mRNA CTD PMID:19483382 cobalt atom multiple interactions ISO RGD:1350913 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of BNIP3 mRNA, [tungsten carbide co-treated with Cobalt] results in increased expression of BNIP3 mRNA CTD PMID:18078969 , PMID:20105288 cobalt atom increases expression EXP 6480464 Cobalt results in increased expression of BNIP3 protein CTD PMID:24824807 cobalt atom increases expression ISO RGD:1350913 6480464 Cobalt results in increased expression of BNIP3 protein CTD PMID:24824807 cobalt dichloride multiple interactions ISO RGD:1350913 6480464 HIF1A mutant form inhibits the reaction [cobaltous chloride results in increased expression of BNIP3 mRNA] more ... CTD PMID:22269387 , PMID:25100165 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of BNIP3 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1350913 6480464 cobaltous chloride results in increased expression of BNIP3 mRNA CTD PMID:19320972 more ... cobalt dichloride increases expression ISO RGD:733814 6480464 cobaltous chloride results in increased expression of BNIP3 mRNA, cobaltous chloride results in increased expression of BNIP3 protein CTD PMID:15375294 more ... cocaine affects expression ISO RGD:733814 6480464 Cocaine affects the expression of BNIP3 mRNA CTD PMID:15681117 concanamycin A increases expression ISO RGD:1350913 6480464 concanamycin A results in increased expression of BNIP3 mRNA CTD PMID:25981168 concanamycin A multiple interactions ISO RGD:1350913 6480464 lapatinib inhibits the reaction [concanamycin A results in increased expression of BNIP3 mRNA] CTD PMID:25981168 copper atom multiple interactions ISO RGD:733814 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BNIP3 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:733814 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BNIP3 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:1350913 6480464 Copper Sulfate results in decreased expression of BNIP3 mRNA CTD PMID:19549813 cycloheximide multiple interactions ISO RGD:733814 6480464 Cycloheximide inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 cyclosporin A increases expression ISO RGD:1350913 6480464 Cyclosporine results in increased expression of BNIP3 mRNA CTD PMID:25596134 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of BNIP3 mRNA CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:1350913 6480464 Cyclosporine results in decreased expression of BNIP3 mRNA CTD PMID:21632981 , PMID:25562108 deoxycholic acid affects response to substance ISO RGD:1350913 6480464 BNIP3 protein affects the susceptibility to Deoxycholic Acid CTD PMID:12507930 dexamethasone increases expression ISO RGD:733814 6480464 Dexamethasone results in increased expression of BNIP3 mRNA CTD PMID:21041162 dexamethasone decreases expression ISO RGD:1350913 6480464 Dexamethasone results in decreased expression of BNIP3 mRNA CTD PMID:25047013 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BNIP3 mRNA CTD PMID:19730151 diarsenic trioxide increases expression ISO RGD:1350913 6480464 Arsenic Trioxide results in increased expression of BNIP3 mRNA, Arsenic Trioxide results in increased expression of BNIP3 protein CTD PMID:15592527 , PMID:17530438 diarsenic trioxide increases response to substance ISO RGD:1350913 6480464 BNIP3 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:15592527 diarsenic trioxide multiple interactions ISO RGD:1350913 6480464 [Arsenic Trioxide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of BNIP3 mRNA, Arsenic Trioxide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BNIP3 mRNA] CTD PMID:25446377 diazinon increases methylation ISO RGD:1350913 6480464 Diazinon results in increased methylation of BNIP3 gene CTD PMID:22964155 diazinon affects expression EXP 6480464 Diazinon affects the expression of BNIP3 mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression ISO RGD:733814 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:733814 6480464 Dibutyl Phthalate results in decreased expression of BNIP3 mRNA CTD PMID:21266533 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of BNIP3 mRNA CTD PMID:22546817 diethylstilbestrol increases expression ISO RGD:733814 6480464 Diethylstilbestrol results in increased expression of BNIP3 mRNA CTD PMID:21041162 dioxygen affects expression ISO RGD:733814 6480464 Oxygen deficiency affects the expression of BNIP3 mRNA CTD PMID:17193925 dioxygen multiple interactions EXP 6480464 Tea inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 protein] CTD PMID:29139225 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of BNIP3 protein CTD PMID:29139225 dioxygen increases expression ISO RGD:1350913 6480464 Oxygen deficiency results in increased expression of BNIP3 mRNA, Oxygen deficiency results in increased expression of BNIP3 protein CTD PMID:17914565 more ... dioxygen multiple interactions ISO RGD:1350913 6480464 [2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one co-treated with Oxygen deficiency] results in increased expression of BNIP3 mRNA more ... CTD PMID:26082309 , PMID:29690507 dioxygen increases expression ISO RGD:733814 6480464 Oxygen deficiency results in increased expression of BNIP3 mRNA CTD PMID:20880076 , PMID:23624791 dopamine increases expression ISO RGD:1350913 6480464 [Dopamine results in increased expression of HIF1A protein] which results in increased expression of BNIP3 mRNA, [Dopamine results in increased expression of HIF1A protein] which results in increased expression of BNIP3 protein CTD PMID:19410601 dorsomorphin multiple interactions ISO RGD:1350913 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BNIP3 mRNA CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:733814 6480464 PARP1 protein promotes the reaction [Doxorubicin results in increased expression of BNIP3 mRNA] CTD PMID:19001878 doxorubicin increases expression ISO RGD:1350913 6480464 Doxorubicin results in increased expression of BNIP3 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:733814 6480464 Doxorubicin results in increased expression of BNIP3 mRNA CTD PMID:19001878 , PMID:25896364 doxorubicin decreases expression ISO RGD:1350913 6480464 Doxorubicin results in decreased expression of BNIP3 mRNA CTD PMID:22908232 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BNIP3 mRNA CTD PMID:29391264 erlotinib hydrochloride multiple interactions ISO RGD:1350913 6480464 Erlotinib Hydrochloride inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 protein] CTD PMID:25981168 ethanol multiple interactions ISO RGD:733814 6480464 Dactinomycin inhibits the reaction [Ethanol results in increased expression of BNIP3 protein], FOXO3 gene mutant form inhibits the reaction [Ethanol results in increased expression of BNIP3 mRNA] CTD PMID:24095927 ethanol affects splicing ISO RGD:733814 6480464 Ethanol affects the splicing of BNIP3 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1350913 6480464 [[Gasoline co-treated with Ethanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BNIP3 mRNA CTD PMID:29432896 ethanol decreases expression ISO RGD:1350913 6480464 Ethanol results in decreased expression of BNIP3 mRNA CTD PMID:28986285 ethanol increases expression ISO RGD:733814 6480464 Ethanol results in increased expression of BNIP3 mRNA, Ethanol results in increased expression of BNIP3 protein CTD PMID:24095927 , PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1350913 6480464 Ethyl Methanesulfonate results in decreased expression of BNIP3 mRNA CTD PMID:23649840 fenamidone decreases expression ISO RGD:733814 6480464 fenamidone results in decreased expression of BNIP3 mRNA CTD PMID:27029645 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of BNIP3 mRNA CTD PMID:25596134 fluoranthene multiple interactions ISO RGD:733814 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of BNIP3 mRNA CTD PMID:28329830 flurbiprofen increases expression ISO RGD:733814 6480464 Flurbiprofen results in increased expression of BNIP3 mRNA CTD PMID:16949054 folic acid affects expression ISO RGD:1350913 6480464 Folic Acid affects the expression of BNIP3 mRNA CTD PMID:17320366 formaldehyde decreases expression ISO RGD:1350913 6480464 Formaldehyde results in decreased expression of BNIP3 mRNA CTD PMID:23649840 gallic acid multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein], ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein]] CTD PMID:29061316 gallocatechin multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein], ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein]] CTD PMID:29061316 gefitinib multiple interactions ISO RGD:1350913 6480464 gefitinib inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 protein] CTD PMID:25981168 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of BNIP3 gene CTD PMID:28505145 geraniol increases expression ISO RGD:1350913 6480464 geraniol results in increased expression of BNIP3 protein CTD PMID:21371438 glutathione multiple interactions ISO RGD:733814 6480464 Glutathione inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 hyaluronic acid multiple interactions EXP 6480464 FG-4592 promotes the reaction [Hyaluronic Acid results in increased expression of BNIP3 protein] CTD PMID:27082295 hyaluronic acid increases expression EXP 6480464 Hyaluronic Acid results in increased expression of BNIP3 protein CTD PMID:27082295 hydrogen peroxide affects expression ISO RGD:1350913 6480464 Hydrogen Peroxide affects the expression of BNIP3 mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO RGD:1350913 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of BNIP3 protein] more ... CTD PMID:29061316 , PMID:30316844 hydrogen peroxide decreases expression ISO RGD:1350913 6480464 Hydrogen Peroxide results in decreased expression of BNIP3 mRNA, Hydrogen Peroxide results in decreased expression of BNIP3 protein CTD PMID:12419474 more ... hydroquinone decreases expression ISO RGD:1350913 6480464 hydroquinone results in decreased expression of BNIP3 mRNA CTD PMID:15452088 ibuprofen increases expression EXP 6480464 Ibuprofen results in increased expression of BNIP3 mRNA CTD PMID:25596134 ifosfamide decreases expression ISO RGD:1350913 6480464 Ifosfamide results in decreased expression of BNIP3 mRNA CTD PMID:25596134 iron atom increases expression ISO RGD:733814 6480464 Iron deficiency results in increased expression of BNIP3 mRNA CTD PMID:23776592 iron(0) increases expression ISO RGD:733814 6480464 Iron deficiency results in increased expression of BNIP3 mRNA CTD PMID:23776592 isobutanol multiple interactions ISO RGD:1350913 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BNIP3 mRNA CTD PMID:29432896 isoflurane increases expression EXP 6480464 Isoflurane results in increased expression of BNIP3 mRNA CTD PMID:16978161 isoprenaline increases expression ISO RGD:733814 6480464 Isoproterenol results in increased expression of BNIP3 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:733814 6480464 Ivermectin results in decreased expression of BNIP3 mRNA CTD PMID:28942281 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of BNIP3 mRNA CTD PMID:20080153 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of BNIP3 mRNA CTD PMID:25808816 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of BNIP3 mRNA CTD PMID:19483382 lapatinib multiple interactions ISO RGD:1350913 6480464 Lapatinib inhibits the reaction [bafilomycin A1 results in increased expression of BNIP3 mRNA], Lapatinib inhibits the reaction [concanamycin A results in increased expression of BNIP3 mRNA] CTD PMID:25981168 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of BNIP3 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BNIP3 mRNA CTD PMID:16401727 , PMID:16415329 lipopolysaccharide increases expression ISO RGD:733814 6480464 Lipopolysaccharides results in increased expression of BNIP3 mRNA, Lipopolysaccharides results in increased expression of BNIP3 protein CTD PMID:21307008 lipopolysaccharide multiple interactions ISO RGD:733814 6480464 HIF1A protein promotes the reaction [Lipopolysaccharides results in increased expression of BNIP3 mRNA] more ... CTD PMID:21307008 maneb increases expression ISO RGD:1350913 6480464 Maneb results in increased expression of BNIP3 mRNA, Maneb results in increased expression of BNIP3 protein CTD PMID:18266926 manganese atom multiple interactions ISO RGD:733814 6480464 Antioxidants inhibits the reaction [Manganese results in increased expression of BNIP3 protein] CTD PMID:19442826 manganese(0) multiple interactions ISO RGD:733814 6480464 Antioxidants inhibits the reaction [Manganese results in increased expression of BNIP3 protein] CTD PMID:19442826 manganese(II) chloride multiple interactions ISO RGD:733814 6480464 [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] more ... CTD PMID:19442826 manganese(II) chloride affects response to substance ISO RGD:733814 6480464 BNIP3 protein affects the susceptibility to manganese chloride CTD PMID:19442826 menadione decreases expression ISO RGD:733814 6480464 Vitamin K 3 results in decreased expression of BNIP3 mRNA CTD PMID:25270620 metformin increases expression EXP 6480464 Metformin results in increased expression of BNIP3 mRNA CTD PMID:25596134 methotrexate affects expression ISO RGD:733814 6480464 Methotrexate affects the expression of BNIP3 mRNA CTD PMID:18502557 methotrexate multiple interactions ISO RGD:1350913 6480464 [Methotrexate co-treated with CDKN1A protein] results in decreased expression of BNIP3 mRNA CTD PMID:18483502 methotrexate affects response to substance ISO RGD:1350913 6480464 BNIP3 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methyl methanesulfonate decreases expression ISO RGD:1350913 6480464 Methyl Methanesulfonate results in decreased expression of BNIP3 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1350913 6480464 methylmercuric chloride results in decreased expression of BNIP3 mRNA CTD PMID:23179753 , PMID:27188386 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA CTD PMID:17905399 Mitotane increases expression EXP 6480464 Mitotane analog results in increased expression of BNIP3 mRNA, Mitotane results in increased expression of BNIP3 mRNA CTD PMID:23485034 monensin A increases expression ISO RGD:1350913 6480464 Monensin results in increased expression of BNIP3 protein CTD PMID:30718715 motexafin gadolinium multiple interactions ISO RGD:1350913 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BNIP3 mRNA CTD PMID:16357179 motexafin gadolinium increases expression ISO RGD:1350913 6480464 motexafin gadolinium results in increased expression of BNIP3 mRNA CTD PMID:16357179 N-[3-(aminomethyl)benzyl]acetamidine multiple interactions ISO RGD:733814 6480464 [N-(3-(aminomethyl)benzyl)acetamidine results in decreased activity of NOS2 protein] inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 N-acetyl-L-cysteine multiple interactions ISO RGD:733814 6480464 Acetylcysteine inhibits the reaction [manganese chloride results in increased expression of BNIP3 protein] CTD PMID:19442826 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1350913 6480464 [arsenic trioxide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of BNIP3 mRNA more ... CTD PMID:25446377 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:1350913 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BNIP3 mRNA CTD PMID:25446377 N-methyl-4-phenylpyridinium decreases expression ISO RGD:733814 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BNIP3 mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of BNIP3 protein CTD PMID:17475336 more ... N-methyl-4-phenylpyridinium increases expression ISO RGD:1350913 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BNIP3 mRNA CTD PMID:18266926 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BNIP3 mRNA CTD PMID:16401727 , PMID:16415329 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of BNIP3 mRNA CTD PMID:24136188 nickel dichloride multiple interactions ISO RGD:733814 6480464 HIF1A affects the reaction [nickel chloride results in increased expression of BNIP3 mRNA] CTD PMID:12426141 , PMID:12729255 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BNIP3 mRNA CTD PMID:22110744 , PMID:22546817 nickel dichloride multiple interactions ISO RGD:1350913 6480464 HIF1A protein promotes the reaction [nickel chloride results in increased expression of BNIP3 protein] CTD PMID:28552779 nickel dichloride increases expression ISO RGD:733814 6480464 nickel chloride results in increased expression of BNIP3 mRNA CTD PMID:12426141 more ... nickel dichloride increases expression ISO RGD:1350913 6480464 nickel chloride results in increased expression of BNIP3 mRNA CTD PMID:17312168 , PMID:28552779 nickel subsulfide affects expression ISO RGD:733814 6480464 nickel subsulfide affects the expression of BNIP3 mRNA CTD PMID:12729255 nickel sulfate increases expression ISO RGD:1350913 6480464 nickel sulfate results in increased expression of BNIP3 mRNA CTD PMID:17382205 nicotine multiple interactions ISO RGD:733814 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of BNIP3 mRNA CTD PMID:24136188 nitric oxide increases expression EXP 6480464 Nitric Oxide results in increased expression of BNIP3 protein CTD PMID:16002567 nitric oxide decreases expression ISO RGD:733814 6480464 Nitric Oxide results in decreased expression of BNIP3 mRNA CTD PMID:11592958 nitrogen dioxide increases expression ISO RGD:1350913 6480464 Nitrogen Dioxide results in increased expression of BNIP3 mRNA CTD PMID:27206323 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of BNIP3 mRNA CTD PMID:19562491 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of BNIP3 mRNA CTD PMID:19483382 oxaliplatin decreases expression ISO RGD:1350913 6480464 oxaliplatin results in decreased expression of BNIP3 mRNA CTD PMID:17762391 p-menthan-3-ol decreases expression ISO RGD:1350913 6480464 Menthol results in decreased expression of BNIP3 mRNA CTD PMID:26760959 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of BNIP3 mRNA CTD PMID:27638505 paeoniflorin multiple interactions ISO RGD:1350913 6480464 peoniflorin inhibits the reaction [cobaltous chloride results in increased expression of BNIP3 mRNA] CTD PMID:22269387 paracetamol multiple interactions ISO RGD:1350913 6480464 [Dietary Carbohydrates co-treated with Acetaminophen] results in decreased expression of BNIP3 mRNA CTD PMID:17093179 paracetamol increases expression ISO RGD:1350913 6480464 Acetaminophen results in increased expression of BNIP3 mRNA CTD PMID:25596134 paracetamol decreases expression ISO RGD:1350913 6480464 Acetaminophen results in decreased expression of BNIP3 mRNA CTD PMID:25704631 paraquat decreases expression ISO RGD:1350913 6480464 Paraquat results in decreased expression of BNIP3 mRNA CTD PMID:18836921 paraquat affects response to substance ISO RGD:1350913 6480464 BNIP3 protein affects the susceptibility to Paraquat CTD PMID:18056701 paraquat increases expression ISO RGD:733814 6480464 Paraquat results in increased expression of BNIP3 protein CTD PMID:18056701 paraquat increases expression ISO RGD:1350913 6480464 Paraquat results in increased expression of BNIP3 mRNA, Paraquat results in increased expression of BNIP3 protein CTD PMID:18056701 more ... pentobarbital increases expression EXP 6480464 Pentobarbital results in increased expression of BNIP3 mRNA CTD PMID:16978161 peroxynitrous acid increases expression ISO RGD:1350913 6480464 Peroxynitrous Acid results in increased expression of BNIP3 protein CTD PMID:16002567 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of BNIP3 mRNA CTD PMID:19483382 pirinixic acid increases expression ISO RGD:733814 6480464 pirinixic acid results in increased expression of BNIP3 mRNA CTD PMID:17118139 more ... pregnenolone 16alpha-carbonitrile increases expression ISO RGD:733814 6480464 Pregnenolone Carbonitrile results in increased expression of BNIP3 mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:733814 6480464 propiconazole results in decreased expression of BNIP3 mRNA CTD PMID:21278054 propofol multiple interactions ISO RGD:733814 6480464 Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 mRNA], Propofol inhibits the reaction [Lipopolysaccharides results in increased expression of BNIP3 protein] CTD PMID:21307008 quercetin affects expression EXP 6480464 Quercetin affects the expression of BNIP3 mRNA CTD PMID:18178720 quercetin decreases expression ISO RGD:1350913 6480464 Quercetin results in decreased expression of BNIP3 mRNA CTD PMID:21632981 quercetin increases expression ISO RGD:1350913 6480464 Quercetin results in increased expression of BNIP3 mRNA CTD PMID:19729006 quinolone increases expression ISO RGD:1350913 6480464 Quinolones results in increased expression of BNIP3 mRNA CTD PMID:26082309 quinolone multiple interactions ISO RGD:1350913 6480464 [Quinolones co-treated with Oxygen deficiency] results in increased expression of BNIP3 mRNA, Quinolones inhibits the reaction [Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of BNIP3 protein]] CTD PMID:26082309 rac-lactic acid decreases expression ISO RGD:1350913 6480464 Lactic Acid results in decreased expression of BNIP3 mRNA CTD PMID:30851411 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of BNIP3 mRNA CTD PMID:16401727 , PMID:16415329 rotenone increases expression ISO RGD:733814 6480464 Rotenone results in increased expression of BNIP3 mRNA CTD PMID:19304788 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BNIP3 mRNA CTD PMID:28374803 S-nitrosoglutathione decreases expression ISO RGD:733814 6480464 S-Nitrosoglutathione results in decreased expression of BNIP3 mRNA CTD PMID:11592958 SB 431542 multiple interactions ISO RGD:1350913 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BNIP3 mRNA CTD PMID:27188386 simvastatin increases expression ISO RGD:1350913 6480464 Simvastatin results in increased expression of BNIP3 mRNA CTD PMID:17428261 sirolimus multiple interactions ISO RGD:733814 6480464 Sirolimus inhibits the reaction [IL2 protein results in increased expression of BNIP3 mRNA] CTD PMID:11355896 sodium arsenite multiple interactions ISO RGD:1350913 6480464 [CARM1 mutant form co-treated with sodium arsenite] results in increased expression of BNIP3 mRNA, [PRMT1 mutant form co-treated with sodium arsenite] results in increased expression of BNIP3 mRNA CTD PMID:23699174 sodium arsenite increases expression ISO RGD:1350913 6480464 sodium arsenite results in increased expression of BNIP3 mRNA CTD PMID:20886546 , PMID:28229933 sodium arsenite decreases expression ISO RGD:1350913 6480464 sodium arsenite results in decreased expression of BNIP3 mRNA CTD PMID:12760830 tamoxifen affects expression ISO RGD:733814 6480464 Tamoxifen affects the expression of BNIP3 mRNA CTD PMID:17555576 teriflunomide increases expression ISO RGD:1350913 6480464 A 771726 results in increased expression of BNIP3 mRNA CTD PMID:29427785 tert-butyl hydroperoxide decreases expression ISO RGD:1350913 6480464 tert-Butylhydroperoxide results in decreased expression of BNIP3 mRNA CTD PMID:12419474 tert-butyl hydroperoxide increases expression ISO RGD:733814 6480464 tert-Butylhydroperoxide results in increased expression of BNIP3 mRNA CTD PMID:15003993 tetrachloroethene increases expression ISO RGD:733814 6480464 Tetrachloroethylene results in increased expression of BNIP3 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:733814 6480464 Carbon Tetrachloride results in decreased expression of BNIP3 mRNA CTD PMID:17084009 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BNIP3 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BNIP3 mRNA] CTD PMID:31150632 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of BNIP3 mRNA CTD PMID:15963342 tetrachloromethane increases expression ISO RGD:733814 6480464 Carbon Tetrachloride results in increased expression of BNIP3 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:733814 6480464 CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of BNIP3 mRNA] CTD PMID:17084009 tetraethylenepentamine multiple interactions ISO RGD:1350913 6480464 tetraethylenepentamine inhibits the reaction [cobaltous chloride results in increased expression of BNIP3 mRNA] CTD PMID:25100165 thapsigargin decreases expression ISO RGD:733814 6480464 Thapsigargin results in decreased expression of BNIP3 protein CTD PMID:24648495 thapsigargin decreases expression ISO RGD:1350913 6480464 Thapsigargin results in decreased expression of BNIP3 mRNA CTD PMID:22378314 thimerosal decreases expression ISO RGD:1350913 6480464 Thimerosal results in decreased expression of BNIP3 mRNA CTD PMID:27188386 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of BNIP3 mRNA CTD PMID:19483382 titanium dioxide decreases expression ISO RGD:733814 6480464 titanium dioxide results in decreased expression of BNIP3 mRNA CTD PMID:23557971 trichloroethene multiple interactions ISO RGD:733814 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of BNIP3 protein] CTD PMID:15363585 trichloroethene increases expression ISO RGD:733814 6480464 Trichloroethylene results in increased expression of BNIP3 mRNA CTD PMID:15363585 , PMID:28973375 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA CTD PMID:17905399 trichostatin A increases expression ISO RGD:1350913 6480464 trichostatin A results in increased expression of BNIP3 mRNA CTD PMID:24935251 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of BNIP3 mRNA CTD PMID:25596134 Tungsten carbide multiple interactions ISO RGD:1350913 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of BNIP3 mRNA, [tungsten carbide co-treated with Cobalt] results in increased expression of BNIP3 mRNA CTD PMID:18078969 , PMID:20105288 Tungsten carbide increases expression ISO RGD:1350913 6480464 tungsten carbide results in increased expression of BNIP3 mRNA CTD PMID:20105288 tunicamycin decreases expression ISO RGD:1350913 6480464 Tunicamycin results in decreased expression of BNIP3 mRNA CTD PMID:22378314 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of BNIP3 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:733814 6480464 Valproic Acid affects the expression of BNIP3 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid decreases expression ISO RGD:1350913 6480464 Valproic Acid results in decreased expression of BNIP3 mRNA CTD PMID:19949822 more ... valproic acid increases expression ISO RGD:1350913 6480464 Valproic Acid results in increased expression of BNIP3 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1350913 6480464 Valproic Acid affects the expression of BNIP3 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1350913 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:25446377 , PMID:27188386 valproic acid increases methylation ISO RGD:1350913 6480464 Valproic Acid results in increased methylation of BNIP3 gene CTD PMID:29154799 vincristine multiple interactions ISO RGD:1350913 6480464 Vincristine affects the reaction [Valproic Acid affects the localization of BNIP3 protein] CTD PMID:25446377 vincristine decreases expression ISO RGD:1350913 6480464 Vincristine results in decreased expression of BNIP3 mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1350913 6480464 vorinostat results in decreased expression of BNIP3 mRNA CTD PMID:27188386 zinc acetate multiple interactions ISO RGD:1350913 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of BNIP3 mRNA CTD PMID:16357179 zinc acetate increases expression ISO RGD:1350913 6480464 Zinc Acetate results in increased expression of BNIP3 mRNA CTD PMID:16357179 zinc oxide increases expression ISO RGD:1350913 6480464 Zinc Oxide results in increased expression of BNIP3 mRNA CTD PMID:19755143 zoledronic acid decreases expression ISO RGD:1350913 6480464 zoledronic acid results in decreased expression of BNIP3 mRNA CTD PMID:19036117 zoledronic acid increases expression ISO RGD:1350913 6480464 zoledronic acid results in increased expression of BNIP3 mRNA CTD PMID:25596134
Gene-Chemical Interaction Annotations
